Description
| Product Name | CAT.No | Size |
| PAPP-A & fβhCG Control Level 1 | BXC0337A | 1 x 0.5ml |
| PAPP-A & fβhCG Control Level 2 | BXC0338A | 1 x 0.5ml |
| PAPP-A & fβhCG Control Level 3 | BXC0339A | 1 x 0.5ml |
| PAPP-A Control | BXC0240A | 1 x 0.5ml |
Product Description
The Biorex Diagnostics PAPP-A Controls are human serum–based, assayed quality control materials designed to ensure precise, accurate, and reproducible measurement of Pregnancy-Associated Plasma Protein A (PAPP-A) in maternal serum. PAPP-A is a key biomarker used in first-trimester prenatal screening for chromosomal abnormalities and other pregnancy-related risk assessments. Accurate and reliable laboratory measurement is essential to support informed clinical decisions, maternal–foetal monitoring, and early intervention where necessary.
These controls are prepared from human serum to closely mimic patient samples, providing clinically relevant conditions for assay verification. Multiple control levels allow laboratories to assess performance across the full analytical range, covering low, normal, and elevated concentrations. This ensures that laboratories can detect deviations, maintain consistent performance, and validate assay precision at all clinically significant levels. The formulation is stable and reliable, suitable for routine workflows and long-term storage, which supports consistent testing across multiple runs and instruments.
Key Features
- Human serum–based – replicates patient samples for accurate and relevant testing conditions.
- Multiple control levels – enables comprehensive monitoring of assay performance across the clinical range.
- Automated and semi-automated analyser compatibility – supports diverse laboratory instrumentation.
- Stable and reliable formulation – ensures reproducibility and minimises variability in routine use.
- Quality and compliance – supports adherence to ISO 15189, CAP, and other international quality standards.
Benefits
Routine use of the Biorex PAPP-A Controls allows laboratories to maintain high standards in prenatal screening assays, ensuring reliable, reproducible, and clinically meaningful results. These controls support the accurate assessment of maternal serum, enabling early detection of risk factors and facilitating informed prenatal care. By integrating these controls into laboratory practice, clinicians can trust the accuracy of PAPP-A measurements for patient counselling, risk stratification, and monitoring. The controls also strengthen laboratory quality assurance programs, ensuring compliance with regulatory requirements and enhancing confidence in prenatal screening outcomes. Suitable for clinical and research applications, these controls help laboratories achieve consistent, dependable performance in maternal serum testing and contribute to improved patient care in obstetric practice.
Contact Us for more information.